42 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
45
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.

Washington University
19
Synthesis and in vitro evaluation ofa-synuclein ligands.

Washington University
8
Novel Heterocyclic Piperazine Amide Derivatives as Alpha-synuclein PET Ligands for Diagnosis of Parkinson's Disease.

Emory University
6
Imaging Alpha-synuclein with Novel 5H-Imidazo[1,5-b][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's Disease.

Emory University
2
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tau.

Purdue University
4
In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole.

Zhengzhou University
3
The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers.

Zhengzhou University
5
Therapeutic potential of Coumarin-polyphenolic acid hybrids in PD: Inhibition of α-Syn aggregation and disaggregation of preformed fibrils, leading to reduced neuronal inclusion formation.

Zhengzhou University
4
Novel 4-triazole phenyl amide (4-TPA) molecules: Potent promoters of α-synuclein fibril disassembly.

Fudan University
3
Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants.

University of Agronomic Sciences and Veterinary Medicine of Bucharest
36
Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins.

Sichuan University
2
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates.

Sun Yat-sen University
43
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity.

German University in Cairo
5
Pyrazolamide derivatives inhibit α-Synuclein aggregation, disaggregate preformed fibers, and reduce inclusion formation in neuron cells.

Zhengzhou University
26
Structure-Activity Relationships of Cyano-substituted Indole Derivatives as Ligands for α-Synuclein Aggregates.

Beijing Normal University
7
Hybrids of polyphenolic/quinone acids, the potential preventive and therapeutic drugs for PD: Disaggregate α-Syn fibrils, inhibit inclusions, and repair damaged neurons in mice.

Zhengzhou University
2
Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates.

Sun Yat-Sen University
5
Bis-chalcone polyphenols with potential preventive and therapeutic effects on PD: Design, synthesis and in vitro disaggregation activity against α-synuclein oligomers and fibrils.

Zhengzhou University
4
4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril.

Zhengzhou University
3
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.

Sun Yat-Sen University
28
Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.

Csir-Indian Institute of Chemical Technology (CSIR-IICT)
15
Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.

IQM-CSIC
32
Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.

Universite Grenoble Alpes
9
Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects.

German University In Cairo
4
Hybrids of polyphenolic acids and xanthone, the potential preventive and therapeutic effects on PD: Design, synthesis, in vitro anti-aggregation of α-synuclein, and disaggregation against the existed α-synuclein oligomer and fibril.

Zhengzhou University
33
Discovery of styrylaniline derivatives as novel alpha-synuclein aggregates ligands.

Fudan University
47
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.

University of Catania
14
Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system.

Fudan University
7
Amide derivatives of Gallic acid: Design, synthesis and evaluation of inhibitory activities against in vitro α-synuclein aggregation.

Zhengzhou University
6
Anti-oligomerization sheet molecules: Design, synthesis and evaluation of inhibitory activities against α-synuclein aggregation.

Zhengzhou University
4
Novel Bis-heteroaryl Derivatives To Modulate Protein Aggregation for the Treatment of Neurodegenerative Diseases.

Drexel University
2
A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity.

National Institute of Immunology
33
BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES

Hoffmann-La Roche
15
NOVEL DIOXANE DERIVATIVES

Boehringer Ingelheim International
9
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

Regents of The University of Colorado, A Body Corporate
215
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Galapagos
90
USP30 inhibitors

Mitobridge
33
Imidazo isoindole derivative, preparation method therefor and medical use thereof

Jiangsu Hengrui Medicine
102
PSMA imaging agents

Siemens Medical Solutions Usa
42
Spiro-cyclic amine derivatives as S1P modulators

Abbvie
21
Dipeptidyl-quinolone derivatives inhibit hypoxia inducible factor-1a prolyl hydroxylases-1, -2, and -3 with altered selectivity.

Amgen
4
Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.

University of Rochester